Lipotec’s Eyeseryl wins award

Eyeseryl, one of the latest peptides launched by Lipotec, recently received the New Technology Award 2005 at the HBA (Health & Beauty America) Conference & Exhibition which took place in New York.

Eyeseryl is a synthetic tetrapeptide with antioedema properties specifically designed to reduce puffiness around the eyes. Eyeseryl was officially launched at PCIA 2005 in Bangkok and has quickly made a significant, positive impact. It is soon expected to become a worldwide reference, especially for cosmetic products developed for use around the eye. Following its worldwide success with its anti-wrinkle hexapeptide Argireline, Lipotec has continued developing synthetic peptides for cosmetic use – and Eyeseryl is the latest example.

Latest Issues

Connex-C Asia 2026

Lee Kong Chian School of Medicine, Ong Tiong Tat and Irene Tan Liang Kheng Auditorium
23rd - 24th July 2026

IFSCC Congress 2026

Perth Convention & Exhibition Centre, Perth, Australia
28th September - 1st October